Vaccine Information: ASTRAZENECA COVID-19 VACCINE

ASTRAZENECA COVID-19 VACCINE- azd-1222 injection, suspension
AstraZeneca Pharmaceuticals LP

Package/Label Display Panel – Vial Label

AstraZeneca COVID-19 Vaccine NDC 0310-1222-10

For use under Emergency Use Authorization

Suspension for Intramuscular Injection

After first use, discard after:

6 hours at 20°-25°C (68°-77°F), or

48 hours at 2°-8°C (36°-46°F)

For Exp Date: see

www.azcovid-19.com

Multi-dose vial (10 doses of 0.5 mL)

vial_label_5ml
(click image for full-size original)

Package/Label Display Panel – Vial Carton

NDC 0310-1222-15

AstraZeneca COVID-19 Vaccine

For use under Emergency Use Authorization

Suspension for Intramuscular Injection

Store at 2°-8°C (36°-46°F) in original carton to protect from light.

Do not freeze or shake. No preservative.

Discard 6 hours after first use when held at 20°-25°C (68°-77°F).

Discard 48 hours after first use when held at 2°-8°C (36°-46°F).

10 Multi-dose vials

(each vial contains 10 doses of 0.5 mL)

AstraZeneca

carton_label
(click image for full-size original)
ASTRAZENECA COVID-19 VACCINE
azd1222 injection, suspension
Product Information
Product Type VACCINE Item Code (Source) NDC:0310-1222
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
AZD-1222 (AZD-1222) AZD-1222 50000000000 {VP} in 0.5 mL
Inactive Ingredients
Ingredient Name Strength
HISTIDINE
HISTIDINE MONOHYDROCHLORIDE
MAGNESIUM CHLORIDE
POLYSORBATE 80
ALCOHOL
SUCROSE
SODIUM CHLORIDE
EDETATE DISODIUM
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0310-1222-15 10 VIAL, MULTI-DOSE in 1 CARTON contains a VIAL, MULTI-DOSE (0310-1222-10)
1 NDC:0310-1222-10 5 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (0310-1222-15)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 12/22/2020
Labeler — AstraZeneca Pharmaceuticals LP (054743190)
Registrant — AstraZeneca PLC (230790719)

Revised: 12/2020 AstraZeneca Pharmaceuticals LP

VxLabels.com provides trustworthy package insert and label information about marketed drugs and vaccines as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VxLabels.com. Every individual vaccine label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Vaccine Sections

Vaccine Information by RSS

As the leading independent provider of trustworthy vaccine information, our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VxLabels.com provides the full vaccine subset of the FDA's repository. Vaccine information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.